RARE — Ultragenyx Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual balance sheet for Ultragenyx Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	755	1,202	740	748	577
Net Total Accounts Receivable
Net Total Receivables	32.8	23.1	28.4	40.4	73.4
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	851	1,295	857	884	732
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	74.7	114	176	286	314
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,135	1,760	1,522	1,545	1,491
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	103	190	181	261	280
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	482	605	600	1,193	1,216
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	654	1,154	923	352	275
Total Liabilities & Shareholders' Equity	1,135	1,760	1,522	1,545	1,491
Total Common Shares Outstanding